Events & Presentations

September 25, 2023

The pharmaphorum podcast

Listen to our CEO, Young Kwon discuss Alchemab's innovative platform and its novel approach to drug discovery on the pharmaphorum podcast.

Learn More

September 5, 2023

Young at the Wells Fargo 2023 Healthcare Conference

Listen to CEO Young Kwon chat with Wells Fargo analyst Derek Archila at the Wells Fargo 2023 Healthcare Conference. Live webcast scheduled for Sep 7, 2023 at 4:30 pm ET.

Learn More

August 23, 2023

The Optimum Perspectives Podcast

Our CEO Young Kwon was delighted to speak with Richard Staines of the Optimum  Perspectives Podcast on how Alchemab is revolutionizing antibody drug discovery with a novel alternative to the classic "choose a target" approach.

Learn More

June 21, 2023

Alchemab unveils Alzheimer’s candidate ATLX-1088 targeting CD33 at the Antibody Industrial Symposium 2023

Alchemab's Sandrine Legg, Director of Phenotypic Screening presented data on a potential first-in-class disease-modifying therapeutic for Alzheimer's disease at the Antibody Industrial Symposium in Tours, France on 22 June 2023.

Learn More

May 5, 2023

Alchemab presents new data at CHDI Huntington’s Disease Therapeutics Conference 2023

Alchemab’s Donna Finch, Head of Translational and Clinical Science, presented data on a potential first-in-class disease modifying therapeutic for Huntington’s Disease at the annual CHDI Huntington’s Disease Therapeutics Conference in Dubrovnik, Croatia, on the 26 April 2023.

Learn More

14th November 2022

Jane talks at PEGS 2022

Watch Jane's talks at PEGS 2022

Learn More

04/05/2022

Jane talks at Genomics England Research Summit

Watch our CSO Jane Osbourn give a talk at the Genomics England Research Summit presenting our incredible work to date!

Learn More

4th May 2022

PEGS-2022-thumb

PEGS Boston 2022 – Parallel Discovery of Therapeutic Antibodies and Novel Targets Using Antibody Repertoires of Resilient Individuals

Watch Jorge Dias, Alchemab Principal Scientist and early member of the team, talk at PEGS Boston on ‘Parallel Discovery of Therapeutic Antibodies and Novel Targets Using Antibody Repertoires of Resilient Individuals’

Learn More

4th May 2022

Mining-the-immune-system-for-protective-antibodies-GEL-thumb

Genomics England Research Summit – Mining the immune system for protective antibodies

Learn more about B cell immune repertoires from Jane Osbourn, Alchemab CSO & co-founder, presenting at the Genomics England Research Summit

Learn More

24th March 2022

GTC 2022

Catch a replay of Alchemab’s Jin Leem presenting at Nvidia’s GTC 2022 on deciphering the language of antibodies

Learn More